28.1 -0.25 (-0.88%) Sell

ASHAPURMIN continues its fall as more investors loose confidence

13 min read

ASHAPURA MINECHEM LTD ranked worse than it's peers today. It lost -0.88% to close at 28.1. It's recent 5 day performance has been -0.7%, +0.88%, -0.53%, -0.52% and -1.04%.

[Themes containing ASHAPURMIN]

ASHAPURMIN is currently in a down trend. Over the last three months trading short signals has not been a profitable strategy for ASHAPURMIN's investors in general. However, this strategy had significantly lower risk when compared to Buy-and-Hold investing (which returned +2.0%). It is therefore better to tread with caution in the current downtrend by limiting your allocation to ASHAPURMIN.


ASHAPURMIN has been underperforming the NIFTY-50 index in recent time, after having outperformed till 8 Jan, 2016. Over the last 3 years and 1 month, ASHAPURMIN underperformed the NIFTY-50 index on 60% days.

During the last three months ASHAPURMIN delivered losses on 67% days. However, it still managed to end this period in a profit. It's best return during this period (of +16.09%) was on Monday, 19 Nov, 2018. While it's worst loss in the same period (of -5.42%) was on Friday, 21 Dec, 2018. There was initially a bearish trend during this period which started on 9 Nov, 2018 and went on till 15 Nov, 2018. The trend delivered -12.84% losses to investors. This was followed by a bullish trend that started on 14 Dec, 2018 and ended on 19 Dec, 2018. This bullish trend delivered +16.33% to investors.

ASHAPURMIN had 5 profitable and 7 loss making months over the last year. ASHAPURMIN was profitable in more months than NIFTY-50 index. ASHAPURMIN was also a more risky investment than NIFTY-50 index as it's worst month in the last year, Sep 2018, returned -33.47% compared to -6.42% returned by NIFTY-50 index in Sep 2018. ASHAPURMIN and NIFTY-50 index, both had periods of 2 consecutive profitable months. It is interesting to note that both ASHAPURMIN and NIFTY-50 index significantly outperform during months when quarterly/annual results are announced.

"Our incomes are like our shoes; if too small, they gall and pinch us; but if too large, they cause us to stumble and to trip.

ASHAPURMIN is becoming less volatile overall. In comparison, the NIFTY-50 index is seeing a fall in volatility. During the last three months, there was a significant fall in ASHAPURMIN's volatility from 24 Oct, 2018 to 16 Jan, 2019. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.

Advanced/professional short-term investors should note that ASHAPURMIN has significant negative skewness in it's return distribution. This indicates that ASHAPURMIN is very risky for short-term investment and can significantly underperform for long durations.

NIFTY-50 index has more chance of extreme outcomes than ASHAPURMIN. Therefore, NIFTY-50 must receive a lower allocation than ASHAPURMIN in your portfolio. NIFTY-50 index usually has shorter drawdown period than ASHAPURMIN.

On a general note (since you are interested in ASHAPURMIN), three small cap instruments that deserve special mention are ASTRAZEN, NIITTECH and VINATIORGA. They have all outperformed the market and must be closely watched for investment opportunities.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter